Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan D Dimitrov

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Cell Reports|April 11, 2019
HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B CellsCyril Planchais, Ayrin Kök, Alexia Kanyavuz, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2024
Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated miceJoshua H Bourne, Gina Perrella, Juma El-Awaisi, et al.
Haematologica|May 30, 2013
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoterYohann Repessé, Ivan Peyron, Jordan D Dimitrov, et al.
Blood|December 7, 2010
Proteolytic antibodies activate factor IX in patients with acquired hemophiliaBharath Wootla, Olivier D Christophe, Ankit Mahendra, et al.
The Journal of Biological Chemistry|April 24, 2026
Impact of heme on the therapeutic efficacy of anti-CD20 antibodiesAnnaelle Marey-Jarossay, Alexia Tavares, Robin V Lacombe, et al.
Journal of Autoimmunity|October 26, 2010
Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficienciesJagadeesh Bayry, Emilie M Fournier, Mohan S Maddur, et al.
Frontiers in Immunology|January 9, 2019
Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1Olivia May, Nicolas S Merle, Anne Grunenwald, et al.
Cell Host & Microbe|July 11, 2023
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controllerLuis M Molinos-Albert, Eduard Baquero, Mélanie Bouvin-Pley, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
The Journal of Experimental Medicine|June 25, 2020
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllersVerena Hehle, Maxime Beretta, Maryline Bourgine, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Cell Reports|April 11, 2019
HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B CellsCyril Planchais, Ayrin Kök, Alexia Kanyavuz, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2024
Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated miceJoshua H Bourne, Gina Perrella, Juma El-Awaisi, et al.
Haematologica|May 30, 2013
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoterYohann Repessé, Ivan Peyron, Jordan D Dimitrov, et al.
Blood|December 7, 2010
Proteolytic antibodies activate factor IX in patients with acquired hemophiliaBharath Wootla, Olivier D Christophe, Ankit Mahendra, et al.
The Journal of Biological Chemistry|April 24, 2026
Impact of heme on the therapeutic efficacy of anti-CD20 antibodiesAnnaelle Marey-Jarossay, Alexia Tavares, Robin V Lacombe, et al.
Journal of Autoimmunity|October 26, 2010
Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficienciesJagadeesh Bayry, Emilie M Fournier, Mohan S Maddur, et al.
Frontiers in Immunology|January 9, 2019
Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1Olivia May, Nicolas S Merle, Anne Grunenwald, et al.
Cell Host & Microbe|July 11, 2023
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controllerLuis M Molinos-Albert, Eduard Baquero, Mélanie Bouvin-Pley, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
The Journal of Experimental Medicine|June 25, 2020
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllersVerena Hehle, Maxime Beretta, Maryline Bourgine, et al.
Pageof 13